2018 Breast Cancer Clinical Case Series: The Year in Review (May 2018)
In-Person Event
May 31, 2018
Philadelphia, Pennsylvania, USA
OVERVIEW
Breast Cancer Clinical Case Series: The Year in Review is organized by Penn Medicine - Continuing Medical and Interprofessional Education and will be held on May 31, 2018 at Rittenhouse Hotel, Philadelphia, Pennsylvania, United States of America.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits.
Conference Description :
The purpose of this educational activity is to bring together breast cancer specialists to highlight the state-of-the-art in multidisciplinary patient care. This activity will feature clinical updates in diagnosis and local, regional, and systemic therapies. Additionally, this activity will review promising clinical trials and clinical controversies in breast cancer management.
Conference Objectives are :
Upon completion of this course, participants should be able to:
• Discuss clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer.
• Assess current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer.
• Examine recent clinical trial results concerning the use of novel breast cancer treatment strategies.
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits.
Conference Description :
The purpose of this educational activity is to bring together breast cancer specialists to highlight the state-of-the-art in multidisciplinary patient care. This activity will feature clinical updates in diagnosis and local, regional, and systemic therapies. Additionally, this activity will review promising clinical trials and clinical controversies in breast cancer management.
Conference Objectives are :
Upon completion of this course, participants should be able to:
• Discuss clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer.
• Assess current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer.
• Examine recent clinical trial results concerning the use of novel breast cancer treatment strategies.
Additional details will be posted as soon as they are available.
KEY DATES
31 May, 2018
Event Start Date
31 May, 2018
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Rittenhouse HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links